News

GSK and Fiocruz have established a relationship in 1985 to manufacture vaccines for public health priorities in Brazil. These include polio, Haemophilus influenzae type b (Hib), measles, mumps,

Meda CEO Anders Lonner said that OTC products is a growing segment and the acquisition of OTC brands further strengthens their presence in this area. The aquired products

Ablynx and Boehringer Ingelheim have signed an agreement in September 2007 to collaborate on the discovery, development and commercialisation of up to 10 different Nanobody therapeutics across areas

Echo Therapeutics is developing needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and Prelude SkinPrep System for transdermal drug delivery. Echo said that

ThermoDox is a proprietary heat-activated liposomal encapsulation of Doxorubicin. Celsion said that ThermoDox is currently being evaluated under a special protocol assessment with the US Food and Drug

As per the terms of the non-exclusive agreement, Boehringer Ingelheim will have access to VTU Technology’s ready-to-use high expression Pichia system in close collaboration with the VTU team

Compound libraries will be screened at the Michigan High Throughput Screening Center under the direction of Robert Kilkuskie. The company said that the antibodies developed in this program

Lannett posted a net loss of $403.561 for the first quarter 2010, or $0.02 loss per diluted share, compared to net loss of $2.86m, or $0.11 per diluted

Catalent said that this expansion will enable the company to offer formulation development and optimisation services in its Winchester, Kentucky facility and complements that site’s existing pilot scale